Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis

NCT01579006 · clinicaltrials.gov ↗

COMPLETED

Status

184

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Tocilizumab

Sponsor

Hoffmann-La Roche

Collaborators

[object Object]